Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Research collaboration with Shionogi

Nemesis Bioscience announces research collaboration with Shionogi

6th July 2020

Announced today that it had reached an agreement on terms for a two-year research collaboration with Shionogi & Co. Ltd. to further develop Nemesis Transmid Technology© for the treatment…
ATELERIX LTD

Atelerix and Perfectus Biomed Group collaborate to improve the storage of COVID-19 test swabs

22nd June 2020

The UK Innovation and Science Seed Fund (UKI2S) is delighted to announce the collaboration of Atelerix and Perfectus Biomed Group, two of UKI2S’s portfolio companies.
Matthew Dreaper

Financial management in a crisis: how can early stage technology companies survive a pandemic

18th June 2020

In the current global climate, many people – and businesses – are struggling. On both a personal and professional level, these are the start of some challenging times…
DNA

Ikarovec awarded grant by Innovate UK to develop new wet AMD gene therapy

15th June 2020

Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, has been awarded £458,740 by Innovate UK…
using laptop

Perfectus Biomed Limited has merged with US Extherid Biosciences to form Perfectus Biomed Group

5th June 2020

Perfectus Biomed Limited are excited to officially announce that our merger with Wyoming based laboratory, Extherid Biosciences, has now been completed.
Dr Carolyn Porter

Keeping operational in COVID: pandemic planning and resilience

2nd June 2020

Dr Carolyn Porter, CEO of CytoSeek, shares her experiences of running a company during the coronavirus pandemic and how the Company was able to keep running as usual through these challenging times.
Steps

The challenges of running a start-up through a pandemic: Hiring

28th May 2020

Atelerix is a biotechnology company providing an innovative solution for storing and transporting cells and tissues at room temperature.
Tim Bestwick

The Role of Public-Private Partnerships in the Future of Fusion Energy

28th April 2020

Tim Bestwick shares his insights on the opportunities and challenges for startups in the fusion energy industry of the future.
Coins

Funding future innovations – UKI2S speaks to OBN

22nd April 2020

UKI2S provides its insights into early stage investment for life science companies and the key things investors are looking for.
bioprocessing technology

MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology

20th April 2020

MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures…
Richard Anderson

Corporate communications in the COVID-19 crisis

9th April 2020

As the COVID-19 pandemic continues, science-based companies are having to adjust their communications strategies.
Counting money

New analysis confirms value of UKI2S investing public money to commercialise public science

30th March 2020

The UK Innovation and Science Seed Fund (UKI2S) has published an independent economic analysis showing how its investment and continuing support…
Lab work

GyreOx announces seed funding to develop novel therapeutics targeting intracellular proteins implicated in cancer and autoimmune diseases

11th March 2020

GyreOx Therapeutics (GyreOx), developing its novel MACRO platform, has launched today with backing from UKI2S and LifeArc.
Barbara Domayne-Hayman

How to build a start-up: Launching early stage science companies

10th February 2020

Barbara Domayne-Hayman is an expert in supporting early stage companies in the UK life sciences industry, both as an entrepreneur and now also on the investment side.
Ikarovec

Ophthalmic gene therapy company Ikarovec launches with £2.5m seed funding

5th February 2020

Founded by UK Innovation & Science Seed Fund (UKI2S) with co-investment from LifeArc & Parkwalk to advance a diabetic macular edema gene therapy and other pipeline products.
che

Expert Interview with serial academic founder Professor Che Connon

6th January 2020

Starting a company will always be daunting, but what specific factors should university spin-outs consider to help the process run smoothly?

lab work

UKI2S, Catapult Ventures and Jonathan Milner invest £500K in gene modulation newcomer Pencil Biosciences

11th December 2019

UK Innovation & Science Seed Fund (UKI2S), Catapult Ventures’ GM&C Life Sciences Fund and Jonathan Milner are pleased to announce an investment in Pencil Biosciences…
ATELERIX LTD

Meet the rising stars of the biotech sector at Genesis 2019

3rd December 2019

At this year’s Genesis Conference, Oliver Sexton, Investment Director at UKI2S, will be introducing some of the brightest and best rising stars of the biotech industry.
Meeting

Policy leaders share ambitious vision for increased R&D investment post-election

27th November 2019

With the General Election now well-underway and the main party manifestos published, what is the policy outlook for science and technology in the next Parliament?
lab work

Spin out secures £1.1M for ground-breaking ‘supercharged’ cell therapies to treat solid tumours

25th November 2019

A University of Bristol spin-out company has raised £1.1 million in funding to develop next generation cell therapies that could open new ways to treat solid tumours…
Linear Diagnostics

Rapid test for gonorrhoea and chlamydia to be developed by University of Birmingham spinout

25th November 2019

University of Birmingham spinout Linear Diagnostics Ltd has raised £2m to develop a rapid test for chlamydia and gonorrhoea which can detect infection from a single sample, allowing diagnosis and treatment in a single patient visit.
Tropic Bioscience selecting talent for your startup

Expert Interview with Gilad Gershon: Selecting the right talent for your start-up

20th November 2019

The success of the UK in starting and growing biotech companies is well known, but for most people the sector is synonymous only with healthcare and new medicines.

ATELERIX LTD

Sanj Kumar joins Atelerix as Chief Business Officer

19th November 2019

Cambridge and Newcastle, UK – Atelerix, pioneers in the storage and transport of cells at room temperature, announced today that it has significantly expanded…
UKI2S win OBN award

OBN Awards Winner Announcement – UKI2S

8th November 2019

UK Innovation & Science Seed Fund (UKI2S) is delighted to announce it is has been awarded ‘Best Sector Support Organisation’ at the 11th Annual OBN Awards celebration last night.
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.